ZA881081B - Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines) - Google Patents

Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)

Info

Publication number
ZA881081B
ZA881081B ZA881081A ZA881081A ZA881081B ZA 881081 B ZA881081 B ZA 881081B ZA 881081 A ZA881081 A ZA 881081A ZA 881081 A ZA881081 A ZA 881081A ZA 881081 B ZA881081 B ZA 881081B
Authority
ZA
South Africa
Prior art keywords
vaccines
diagnostic
preparation
therapeutic purposes
virus antigen
Prior art date
Application number
ZA881081A
Other languages
English (en)
Inventor
Seelig Renate
Peter Seelig Hans
Burckhardt Jean
Original Assignee
Seelig Renate
Peter Seelig Hans
Burckhardt Jean
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seelig Renate, Peter Seelig Hans, Burckhardt Jean filed Critical Seelig Renate
Publication of ZA881081B publication Critical patent/ZA881081B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA881081A 1987-02-20 1988-02-16 Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines) ZA881081B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873705512 DE3705512A1 (de) 1987-02-20 1987-02-20 Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)

Publications (1)

Publication Number Publication Date
ZA881081B true ZA881081B (en) 1988-08-11

Family

ID=6321438

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA881081A ZA881081B (en) 1987-02-20 1988-02-16 Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)

Country Status (3)

Country Link
DE (1) DE3705512A1 (enExample)
SU (1) SU1711676A3 (enExample)
ZA (1) ZA881081B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2129610C1 (ru) * 1997-04-04 1999-04-27 Иркутский научно-исследовательский противочумной институт Сибири и Дальнего Востока Способ выделения днк из микроорганизмов и клеток животных, пригодной для постановки полимеразной цепной реакции
MD34Z5 (ro) * 2008-05-20 2010-01-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Metodă de diagnostic al hepatitei virale B la copii de până la un an
MD1166Z (ro) * 2017-01-19 2018-02-28 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Metodă de testare a sângelui donatorului la markerii hepatitei virale B

Also Published As

Publication number Publication date
DE3705512A1 (de) 1988-09-01
SU1711676A3 (ru) 1992-02-07
DE3705512C2 (enExample) 1991-10-02

Similar Documents

Publication Publication Date Title
ZA90171B (en) Treatment methods and vaccines for stimulating an immune response
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
GR900300069T1 (en) Nanbv diagnostics and vaccines
IL68749A (en) Modified antigens,their preparation and vaccines containing them
EP0283505A4 (en) Vaccine and method of preparation.
IL78913A (en) Synthetic vaccines for foot and mouth disease,their preparation and use
AU1347688A (en) Viral antigen, process for its production, and application in diagnosis and therapy (vaccine)
NL189207C (nl) Flavivirus antigeen, werkwijze ter bereiding daarvan, tussenprodukten en werkwijze ter bereiding van een vaccin tegen japanse encefalitis.
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
NZ221227A (en) Hiv envelope proteins, antigenic fragments vaccines; and diagnostic methods
HUT65448A (en) New immunogenic polypeptides, vaccines containing them and method for preparation and use of them
DE3160264D1 (en) Process for isolating viral glycoproteic antigens, and its use in the preparation of vaccines
ZA904565B (en) Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
EP0467972A4 (en) Rickettsial antigens for vaccination and diagnosis
AU632545B2 (en) Hog cholera virus vaccine and diagnostic
EP0453497A4 (en) Treatment methods and vaccines
IL71953A (en) Malaria associated antigen,process for preparation thereof and vaccine comprising it
ZA881081B (en) Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)
IL81920A (en) Vaccines comprising an antigen and interferon-ypsilon and their preparation
DE3666666D1 (en) Early-summer meningo-encephalitis virus (fsme-virus) vaccine, and method of producing the same
JPS6471488A (en) Preparation of human immunodeficient virus type i antigen, and its use as diagnostic and curing agents
GR3031499T3 (en) Hog cholera virus vaccine and diagnostic.
IL83422A (en) Method for the detection of human b lymphotropic virus antibodies
ZA883365B (en) Newcastle disease virus vaccine and method for the application thereof
IL81475A0 (en) Newcastle disease virus(ndv)vaccine and method for the application thereof